(11S)-12-[(6-tert-butyl-5-methylpyrrolo[2,3-b]pyrazin-3-yl)methyl]-7-methyl-6-[2-methyl-6-(2-methylpropyl)phenyl]-2,2-dioxo-11-(trifluoromethoxymethyl)-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
C39H44F3N7O5S — CID 169233714
Data last refreshed: (MolForge compound catalog, from PubChem)
About (11S)-12-[(6-tert-butyl-5-methylpyrrolo[2,3-b]pyrazin-3-yl)methyl]-7-methyl-6-[2-methyl-6-(2-methylpropyl)phenyl]-2,2-dioxo-11-(trifluoromethoxymethyl)-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
(11S)-12-[(6-tert-butyl-5-methylpyrrolo[2,3-b]pyrazin-3-yl)methyl]-7-methyl-6-[2-methyl-6-(2-methylpropyl)phenyl]-2,2-dioxo-11-(trifluoromethoxymethyl)-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one (PubChem CID 169233714) has the molecular formula C39H44F3N7O5S and a molecular weight of 779.89 g/mol. Its IUPAC name is (11S)-12-[(6-tert-butyl-5-methylpyrrolo[2,3-b]pyrazin-3-yl)methyl]-7-methyl-6-[2-methyl-6-(2-methylpropyl)phenyl]-2,2-dioxo-11-(trifluoromethoxymethyl)-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one.
Molecular Properties
| Compound Name | (11S)-12-[(6-tert-butyl-5-methylpyrrolo[2,3-b]pyrazin-3-yl)methyl]-7-methyl-6-[2-methyl-6-(2-methylpropyl)phenyl]-2,2-dioxo-11-(trifluoromethoxymethyl)-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one |
|---|---|
| PubChem CID | 169233714 |
| Molecular Formula | C39H44F3N7O5S |
| Molecular Weight | 779.89 g/mol |
| Exact Mass | 779.31 |
| IUPAC Name | (11S)-12-[(6-tert-butyl-5-methylpyrrolo[2,3-b]pyrazin-3-yl)methyl]-7-methyl-6-[2-methyl-6-(2-methylpropyl)phenyl]-2,2-dioxo-11-(trifluoromethoxymethyl)-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one |
| SMILES | Cc1cccc(CC(C)C)c1-c1nc2nc(c1C)OC[C@@H](COC(F)(F)F)N(Cc1cnc3cc(C(C)(C)C)n(C)c3n1)C(=O)c1cccc(c1)S(=O)(=O)N2 |
| InChI | InChI=1S/C39H44F3N7O5S/c1-22(2)15-25-12-9-11-23(3)32(25)33-24(4)35-46-37(45-33)47-55(51,52)29-14-10-13-26(16-29)36(50)49(28(20-53-35)21-54-39(40,41)42)19-27-18-43-30-17-31(38(5,6)7)48(8)34(30)44-27/h9-14,16-18,22,28H,15,19-21H2,1-8H3,(H,45,46,47)/t28-/m0/s1 |
| InChIKey | VCDWTGXSLAGOIP-NDEPHWFRSA-N |
| XLogP | 7.28 |
| TPSA | 141.43 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 55 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 779.89 |
| LogP ≤ 5 | 7.28 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 169233714 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.